It can be used as an alternative material for skin irritation tests using experimental animals.
The "LabCyte EPI-MODEL" is a human three-dimensional cultured epidermis that is stratified using normal human epidermal cells. Since it uses human cells, there is no species difference compared to animal experiments, and it has less variability between wells and lots, allowing for highly reproducible test results. 【Features】 ■ It has a three-dimensional structure that is highly differentiated and stratified, similar to human skin structure. ■ Morphologically, it has a structure similar to human skin, consisting of a basal layer, spinous layer, granular layer, and stratum corneum. *For more details, please download the PDF or contact us.
Inquire About This Product
basic information
For more details, please download the PDF or contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or contact us.
catalog（2）
Download All Catalogs![[Research Reagent] Human 3D Cultured Epidermis 'LabSite Epi-Model'](https://image.mono.ipros.com/public/catalog/image/01/773/496832/IPROS02285713241921726649.jpeg?w=120&h=170)
Company information
Our company is a biotechnology firm with the purpose of "developing a business that aims to fundamentally change healthcare in the 21st century, based on tissue engineering that brings about qualitative changes in medical care and aims for regenerative treatment." Our main business objectives include research and development, manufacturing, and sales of regenerative medicine products and related products. We operate a "Regenerative Medicine Products Business" that is subject to the Pharmaceuticals and Medical Devices Act, and a "Research and Development Support Business" that is not subject to this act. Additionally, we provide contract development and manufacturing (CDMO) and contract research organization (CRO) services related to regenerative medicine products, as well as support for compliance with the Act on Ensuring Safety in Regenerative Medicine through our "Regenerative Medicine Contract Business."